DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW. et’al.
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.
Breast Cancer Res Treat 2001; 65: 125-34
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.